References

Adis International (2004) Corticosteroids are the main culprits in drug-induced glaucoma. Drugs & Therapy Perspectives 20, 19–22.
| CrossRef |

AGREE Collaboration (2001) ‘Appraisal of Guidelines for Research and Evaluation (AGREE) Instrument.’ (AGREE Collaboration: London) Available at: http://www.agreecollaboration.com [Verified 18 February 2008]

American Academy of Ophthalmology (2005) ‘Primary open-angle glaucoma preferred practice pattern.’ (American Academy of Ophthalmology: San Francisco)

American Optometric Association (2002) ‘Optometric clinical practice guideline: care of the patient with open angle glaucoma.’ 2nd edn. (American Optometric Association: St Louis)

Bonovas S, Peponis V, Filioussi K (2004a) Diabetes mellitus as a risk factor for primary open-angle glaucoma: a meta-analysis. Diabetic Medicine 21, 609–614.
| CrossRef | CAS |

Bonovas S, Filioussi K, Tsantes A, Peponis V (2004b) Epidemiological association between cigarette smoking and primary open-angle glaucoma: a metaanalysis. Public Health 118, 256–261.
| CrossRef | CAS |

Budenz DL, Anderson DR, Feuer WJ, Beiser JA, Schiffman J, Parrish RK, Piltz-Seymour JR, Gordon MO, Kass MA, Ocular Hypertension Treatment Study Group (2006) Detection and prognostic significance of optic disc hemorrhages during the Ocular Hypertension Treatment Study. Ophthalmology 113, 2137–2143.
| CrossRef |

Burr JM, Mowatt G, Hernández R, Siddiqui MA, Cook J, Lourenco T, Ramsay C, Vale L, Fraser C, Azuara-Blanco A, Deeks J, Cairns J, Wormald R, McPherson S, Rabindranath K, Grant A (2007) The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technology Assessment 11, 1–190.

Centre for Allied Health Evidence (2009) Final Report: Systematic Literature Review on the Detection, Diagnosis, Management and Prevention of Glaucoma. Prepared for NHMRC and the Department of Health and Ageing. Available at http://www.nhmrc.gov.au/_files_nhmrc/file/publications/synopses/cp113.pdf [Verified 1 July 2010]

Friedman DS, Vedula SS (2006) Lens extraction for chronic angle-closure glaucoma. Cochrane Database of Systematic Reviews 3, CD005555
| CAS |

Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN (2004) An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Archives of Ophthalmology 138, S19–S31.
| CrossRef |

Glaucoma Australia (2010) ‘What is glaucoma?’ (Glaucoma Australia: Sydney). Available at http://www.glaucoma.org.au/what.htm [Verified 26 May 2010]

Goldberg I, Graham SL, Healey PR (2002) Primary open-angle glaucoma. The Medical Journal of Australia 177, 535–536.

Hatt S, Wormald R, Burr J (2006) Screening for prevention of optic nerve damage due to chronic open angle glaucoma. Cochrane Database of Systematic Reviews 4, CD006129

Hollows FC, Graham PA (1966) Intraocular pressure, glaucoma, and glaucoma suspects in a defined population. The British Journal of Ophthalmology 50, 570–586.
| CrossRef | CAS |

Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, Nickerson RJ, Pool J, Colton TL, Ganley JP, Loewenstein JI, Dawber TR (1980) The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataracts, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973–1975. Survey of Ophthalmology 24, 335–610.
| CAS |

Leone FT, Fish JE, Szefler SJ, West SL (2003) Systematic review of the evidence regarding potential complications of inhaled corticosteroid use in asthma: collaboration of American College of Chest Physicians, American Academy of Allergy, Asthma, and Immunology, and American College of Allergy, Asthma, and Immunology. Chest 124, 2329–2340.
| CrossRef |

Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E, Early Manifest Glaucoma Trial (2003) Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Archives of Ophthalmology 121, 48–56.

Madden AC, Simmons D, McCarty CA, Khan MA, Taylor HR (2002) Eye health in rural Australia. Clinical & Experimental Ophthalmology 30, 316–321.
| CrossRef |

Medeiros FA, Zangwill LM, Bowd C, Vasile C, Sample PA, Weinreb RN (2007) Agreement between stereophotographic and confocal scanning laser ophthalmoscopy measurements of cup/disc ratio: effect on a predictive model for glaucoma development. Journal of Glaucoma 16, 209–214.
| CrossRef |

Merlin T, Weston A, Tooher R (2009) Extending an evidence hierarchy to include topics other than treatment: revising the Australian ‘levels of evidence’. BMC Medical Research Methodology 9, 34

Mitchell P, Smith W, Attebo K, Healey P (1996) Prevalence of open-angle glaucoma in Australia: the Blue Mountains eye study. Ophthalmology 103, 1661–1669.
| CAS |

National Cancer Institute (2010) ‘Dictionary of cancer terms – watchful waiting.’ (National Cancer Institute: Bethesda, MD) Available at http://nci.nih.gov/dictionary/?CdrID=45942 [Verified 19 July 2010]

National Health and Medical Research Council (2009) ‘NHMRC additional levels of evidence and grades for recommendations for developers of guidelines: Stage 2 consultation.’ (NHMRC: Canberra) Available at http://www.nhmrc.gov.au/guidelines/_files/Stage%202%20Consultation%20Levels%20and%20Grades.pdf) [Verified 20 June 2010]

Netland PA, Wiggs JL, Dreyer EB (1993) Inheritance of glaucoma and genetic counseling of glaucoma patients. International Ophthalmology Clinics 33, 101–120.
| CrossRef | CAS |

Phelps CD, Corbett JJ (1985) Migraine and low-tension glaucoma. A case-control study. Investigative Ophthalmology and Visual Science 26, 1105–1108.
| CAS |

Public Health Resource Unit (2006) ‘10 questions to help you make sense of reviews.’ (Public Health Resource Unit: Oxford) Available at http://www.phru.nhs.uk/Doc_Links/S.Reviews%20Appraisal%20Tool.pdf [Verified 18 February 2008]

Royal College of Ophthalmologists (2004) ‘Guidelines for the management of open angle glaucoma and ocular hypertension.’ (Royal College of Ophthalmologists: London)

Schmier JK, Halpern MT, Jones ML (2007) The economic implications of glaucoma – A literature review. PharmacoEconomics 25, 287–308.
| CrossRef |

Sommer A, Katz J, Quigley HA, Miller NR, Robin AL, Ritcher RC, Witt KA (1991) Clinically detectable nerve fiber layer atrophy precedes the onset of glaucomatous field loss. Archives of Ophthalmology 109, 77–83.
| CAS |

Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, Javitt J (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. Journal of the American Medical Association 266, 369–374.
| CrossRef | CAS |

Tielsch JM, Katz J, Sommer A, Quigley HA, Javitt JC (1994) Family history and the risk of primary open angle glaucoma. The Baltimore Eye Study. Archives of Ophthalmology 112, 69–73.
| CAS |

Tripathi RC, Tripathi BJ, Haggerty C (2003) Drug-induced glaucomas mechanism and management. Drug Safety 26, 749–767.
| CrossRef | CAS |

Weih L, Nanjan M, McCrty C, Taylor H (2001) Prevalence and predictors of open-angle glaucoma: results from the visual impairment project. Ophthalmology 108, 1966–1972.
| CrossRef | CAS |

Wolfs RC, Klaver CC, Ramrattan RS, van Duijn CM, Hofman A, de Jong PT (1998) ‘Genetic risk of primary open-angle glaucoma. Population-based familial aggregation study. Archives of Ophthalmology 116, 1640–1645.
| CAS |

Wood JM, Lacherez PF, Black AA, Cole M, Boon M, Kerr G (2009) Postural Stability and Gait among Older Adults with Age-Related Maculopathy. Investigative Ophthalmology & Visual Science 50, 482–487.
| CrossRef |

Worley A, Grimmer-Somers K (2009) Should we be worried about glaucoma? Why the prevalence of glaucoma is variably reported. Primary Health Care Research and Development 10, 343–356.
| CrossRef |